α2 Antiplasmin - Histology

Relevant Publications

RNA Therapeutics to Control Fibrinolysis: Review on Applications in Biology and Medicine.

Issue Release: 2024

Fibrinolysis biomarker, thrombin, and activated protein C level alterations after coagulation activation depend on type of thrombophilia and clinical phenotype.

Issue Release: 2024

Fibrinolysis is impaired in patients with primary immune thrombocytopenia.

Issue Release: 2024

The Roles of Fibrinolytic Factors in Bone Destruction Caused by Inflammation.

Issue Release: 2024

Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach.

Issue Release: 2024

α2-antiplasmin is associated with macrophage activation and fibrin in a macrophage activation syndrome mouse model.

Issue Release: 2024

Limited value of testing for factor XIII and α2-antiplasmin deficiency in patients with a bleeding disorder of unknown cause.

Issue Release: 2024

A single-center study of reference intervals for TAT, PIC, TM and t-PAIC in healthy older Chinese adults.

Issue Release: 2024

Older females have increased mortality after trauma as compared to younger females and males, associated with increased fibrinolysis.

Issue Release: 2023

Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis.

Issue Release: 2023

Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice.

Issue Release: 2023

SARS-CoV-2 infection results in upregulation of Plasminogen Activator Inhibitor-1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity.

Issue Release: 2023

Inhibition of fibroblast activation protein ameliorates cartilage matrix degradation and osteoarthritis progression.

Issue Release: 2023

Citrullination of α2-antiplasmin is unlikely to contribute to enhanced plasmin generation in COVID-19 pathophysiology.

Issue Release: 2023

\"Super\" SERPINs-A stabilizing force against fibrinolysis in thromboinflammatory conditions.

Issue Release: 2023

Validation of the t-AUCi parameter as a measure of fibrinolysis using rotational thromboelastometry and its application in the assessment of fibrinolytic resistance in septic patients: a prospective observational study: Communication from the ISTH SSC Subcommittee on Fibrinolysis.

Issue Release: 2023

A High-Throughput Small-Angle X-ray Scattering Assay to Determine the Conformational Change of Plasminogen.

Issue Release: 2023

Low factor XIII levels and altered fibrinolysis in patients with multiple myeloma.

Issue Release: 2023

Fluorescent peptide for detecting factor XIIIa activity and fibrin in whole blood clots forming under flow.

Issue Release: 2023

Diurnal Oscillations of Fibrinolytic Parameters in Patients with Acute Myocardial Infarction and Their Relation to Platelet Reactivity: Preliminary Insights.

Issue Release: 2022

What is Tumor Suppression?

What Are the Future Trends in Histological Data Indexing?

What is the Intervillous Space?

What are Centrocytes?

Why is the Nrf2 Pathway Important in Histology?

What is the Morphology of Endothelial Cells?

How Does CRISPR-Cas9 Work?

What are the Components of the PSD Protein Complex?

What is Click Chemistry?

What is Long QT Syndrome?

Partnered Content Networks

Relevant Topics